EdgePoint Investment Group’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,277,964
Closed -$16.6M 46
2022
Q4
$16.6M Hold
2,277,964
0.18% 30
2022
Q3
$15.8M Hold
2,277,964
0.18% 36
2022
Q2
$15.9M Hold
2,277,964
0.14% 32
2022
Q1
$18.8M Hold
2,277,964
0.15% 33
2021
Q4
$24.6M Hold
2,277,964
0.19% 33
2021
Q3
$27.4M Hold
2,277,964
0.21% 33
2021
Q2
$27.6M Sell
2,277,964
-14,200
-0.6% -$176K 0.21% 31
2021
Q1
$31.9M Buy
2,292,164
+300,905
+15% +$4.2M 0.25% 31
2020
Q4
$28.2M Sell
1,991,259
-301,921
-13% -$3.94M 0.25% 29
2020
Q3
$28.3M Buy
+2,293,180
New +$26.6M 0.32% 28

Other funds holding AMYT

EdgePoint Investment Group's AMYT Position: Q1 2023 in Review

EdgePoint Investment Group sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q1 2023, closing a stake of 2,277,964 shares — an estimated $16.6M sold.

EdgePoint Investment Group first reported a position in AMYT in Q3 2020 and held it in 10 quarters. The position peaked at $31.9M in Q1 2021. 79 funds tracked by Wall St. Rank hold AMYT as of Q1 2023.

  • EdgePoint Investment Group reported no remaining Amryt Pharma plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • EdgePoint Investment Group sold 2,277,964 Amryt Pharma plc American Depositary Shares shares in Q1 2023, an estimated $16.6M.
  • EdgePoint Investment Group first reported a position in Amryt Pharma plc American Depositary Shares in Q3 2020 and held it in 10 quarters.
  • EdgePoint Investment Group's Amryt Pharma plc American Depositary Shares position peaked at $31.9M in Q1 2021.
  • 79 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q1 2023.

Based on EdgePoint Investment Group's 13F filing for Q1 2023, filed 15 May 2023.